Crinetics Pharmaceuticals

-$0.52 (-2.11%) As of 3:29 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.

CEO
Scott R. Struthers
Employees
93
Headquarters
San Diego, California
Founded
2008

CRNX Key Statistics

Market cap
1.15B
Price-Earnings ratio
—
Dividend yield
—
Average volume
349.89K
High today
$24.95
Low today
$23.64
Open price
$24.66
Volume
17.43K
52 Week high
$28.78
52 Week low
$12.77

CRNX Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure